Amedeo Smart

Free Medical Literature Service


 

Amedeo

Vaccines

  Free Subscription

Articles published in
Nat Immunol
    September 2021
  1. WOLYNN T, Hermann C
    Shots heard round the world: better communication holds the key to increasing vaccine acceptance.
    Nat Immunol. 2021;22:1068-1070.
    >> Share

  2. FEHERVARI Z
    Intranasal vaccination.
    Nat Immunol. 2021;22:1071.
    >> Share

  3. ALSUWAIDI AR, Al Hosani FI, ElGhazali G, Al-Ramadi BK, et al
    The COVID-19 response in the United Arab Emirates: challenges and opportunities.
    Nat Immunol. 2021;22:1066-1067.
    >> Share

  4. YAO Y, Chen Z, Zhang H, Chen C, et al
    Selenium-GPX4 axis protects follicular helper T cells from ferroptosis.
    Nat Immunol. 2021;22:1127-1139.
    >> Share

    July 2021
  5. CUPOVIC J, Ring SS, Onder L, Colston JM, et al
    Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8(+) T cells.
    Nat Immunol. 2021 Jul 15. pii: 10.1038/s41590-021-00969.
    >> Share

  6. DAI L, Xu K, Li J, Huang Q, et al
    Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch.
    Nat Immunol. 2021 Jul 15. pii: 10.1038/s41590-021-00966.
    >> Share

  7. MUKHTAR MM, Khogali M
    The accelerating COVID-19 epidemic in Sudan.
    Nat Immunol. 2021;22:797-798.
    >> Share

    April 2021
  8. CHEN SC
    Taiwan's experience in fighting COVID-19.
    Nat Immunol. 2021;22:393-394.
    >> Share

    March 2021
  9. GEOGHEGAN JL, Moreland NJ, Le Gros G, Ussher JE, et al
    New Zealand's science-led response to the SARS-CoV-2 pandemic.
    Nat Immunol. 2021;22:262-263.
    >> Share

  10. MADKAIKAR M, Gupta N, Yadav RM, Bargir UA, et al
    India's crusade against COVID-19.
    Nat Immunol. 2021;22:258-259.
    >> Share


  11. Coping with COVID.
    Nat Immunol. 2021;22:255.
    >> Share

    January 2021
  12. NELDE A, Bilich T, Heitmann JS, Maringer Y, et al
    SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
    Nat Immunol. 2021;22:74-85.
    >> Share


  13. Challenges for the Biden presidency.
    Nat Immunol. 2021;22:1.
    >> Share

  14. DIVANGAHI M, Aaby P, Khader SA, Barreiro LB, et al
    Trained immunity, tolerance, priming and differentiation: distinct immunological processes.
    Nat Immunol. 2021;22:2-6.
    >> Share

    November 2020
  15. BAHAROM F, Ramirez-Valdez RA, Tobin KKS, Yamane H, et al
    Intravenous nanoparticle vaccination generates stem-like TCF1(+) neoantigen-specific CD8(+) T cells.
    Nat Immunol. 2020 Nov 2. pii: 10.1038/s41590-020-00810.
    >> Share

  16. PENG Y, Mentzer AJ, Liu G, Yao X, et al
    Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.
    Nat Immunol. 2020;21:1336-1345.
    >> Share

    June 2020
  17. DEMPSEY LA
    Vaccines vs antibiotics.
    Nat Immunol. 2020;21:596.
    >> Share

    February 2020
  18. ROSKIN KM, Jackson KJL, Lee JY, Hoh RA, et al
    Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth.
    Nat Immunol. 2020;21:199-209.
    >> Share

    December 2019
  19. GALANI IE, Klechevsky E, Andreakos E
    Human and translational immunology in the third millennium: progress, challenges and opportunities.
    Nat Immunol. 2019;20:1568-1573.
    >> Share

    September 2019
  20. WARD JK, Peretti-Watel P, Bocquier A, Seror V, et al
    Vaccine hesitancy and coercion: all eyes on France.
    Nat Immunol. 2019 Sep 2. pii: 10.1038/s41590-019-0488.
    >> Share

  21. SLON-CAMPOS JL, Dejnirattisai W, Jagger BW, Lopez-Camacho C, et al
    A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection.
    Nat Immunol. 2019 Sep 2. pii: 10.1038/s41590-019-0477.
    >> Share

    May 2019
  22. YE L, Schnepf D, Becker J, Ebert K, et al
    Interferon-lambda enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin.
    Nat Immunol. 2019;20:593-601.
    >> Share

  23. KOUTSAKOS M, Illing PT, Nguyen THO, Mifsud NA, et al
    Human CD8(+) T cell cross-reactivity across influenza A, B and C viruses.
    Nat Immunol. 2019;20:613-625.
    >> Share

    March 2019
  24. KANEKIYO M, Joyce MG, Gillespie RA, Gallagher JR, et al
    Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses.
    Nat Immunol. 2019;20:362-372.
    >> Share

    February 2019
  25. FEHERVARI Z
    Vaccine sex differences.
    Nat Immunol. 2019;20:111.
    >> Share

    January 2019
  26. ALLIE SR, Bradley JE, Mudunuru U, Schultz MD, et al
    The establishment of resident memory B cells in the lung requires local antigen encounter.
    Nat Immunol. 2019;20:97-108.
    >> Share

    November 2018
  27. COCKBURN IA, Seder RA
    Malaria prevention: from immunological concepts to effective vaccines and protective antibodies.
    Nat Immunol. 2018;19:1199-1211.
    >> Share

    September 2018
  28. ROSENZWEIG SD
    Old vaccines, new diseases: when BCG meets SPPL2a.
    Nat Immunol. 2018;19:906-907.
    >> Share

    June 2018
  29. FEHERVARI Z
    Dysbiosis shapes vaccine responses.
    Nat Immunol. 2018 Jun 20. pii: 10.1038/s41590-018-0151.
    >> Share

    April 2018
  30. UGOLINI M, Gerhard J, Burkert S, Jensen KJ, et al
    Recognition of microbial viability via TLR8 drives TFH cell differentiation and vaccine responses.
    Nat Immunol. 2018;19:386-396.
    >> Share

    December 2017
  31. GRAHAM BS, Sullivan NJ
    Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic.
    Nat Immunol. 2017 Dec 3. pii: 10.1038/s41590-017-0007.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016